Strong Nordic presence: UnoMeterT SafetiT Plus wins tenders in Stockholm and Helsinki/Tampere; footprint established in Denmark with continuous growth

26 Jun 2025 15:30 CEST

Oslo, June 24, 2025 - Observe Medical ("the Company" or "Observe Medical") is
pleased to announce that UnoMeter[TM] Safeti[TM] Plus has been appointed
exclusive winner of the tender in the largest region in Sweden, representing
approximately 20% of the total Swedish market. In Finland UnoMeter[TM]
Safeti[TM] has been awarded the tender for Helsinki and Tampere which represents
approx. 20% of the Finnish market, on a non-exclusive basis. In Denmark supply
contracts has been signed and deliveries have commenced to 3 out of 5 healthcare
regions, representing nearly 60% of the national market.

These market penetration activities and tenders were skillfully managed by
Vingmed which is the Company's distribution partner for the Nordic region and is
a reflection of the markets desire to get back to the quality level that
UnoMeter[TM] Safeti[TM] Plus offers.

Historically the market share of UnoMeter[TM] Safeti[TM] Plus has been very high
in the Nordic region and the market represents a market potential of approx. 40+
mill. NOK. in annual recurring revenue.

Jørgen Mann, CEO of Observe Medical, commented: "Winning major tenders and
signing significant supply contracts in the Nordic region that historically has
been a very strong home region, due to the legacy going back to company
Unomedical which was based in Denmark, is another verification that no
competitor has been able to replace UnoMeter[TM] Safeti[TM] Plus as the
reference point for high quality and clinical performance".

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available atwww.observemedical.com.

More information:
Access the news on Oslo Bors NewsWeb site

650169_Release.pdf